Exact Mass: 442.9842

Exact Mass Matches: 442.9842

Found 40 metabolites which its exact mass value is equals to given mass value 442.9842, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Guanosine diphosphate

[({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C10H15N5O11P2 (443.0243)


Guanosine diphosphate, also known as gdp or 5-diphosphate, guanosine, is a member of the class of compounds known as purine ribonucleoside diphosphates. Purine ribonucleoside diphosphates are purine ribobucleotides with diphosphate group linked to the ribose moiety. Guanosine diphosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Guanosine diphosphate can be found in a number of food items such as strawberry, onion-family vegetables, walnut, and scarlet bean, which makes guanosine diphosphate a potential biomarker for the consumption of these food products. Guanosine diphosphate can be found primarily in blood and cerebrospinal fluid (CSF). Guanosine diphosphate exists in all living species, ranging from bacteria to humans. In humans, guanosine diphosphate is involved in several metabolic pathways, some of which include betahistine h1-antihistamine action, fexofenadine h1-antihistamine action, clocinizine h1-antihistamine action, and bepotastine h1-antihistamine action. Guanosine diphosphate is also involved in several metabolic disorders, some of which include adenine phosphoribosyltransferase deficiency (APRT), canavan disease, gout or kelley-seegmiller syndrome, and pyruvate dehydrogenase complex deficiency. Moreover, guanosine diphosphate is found to be associated with epilepsy, subarachnoid hemorrhage, neuroinfection, and stroke. Guanosine diphosphate, abbreviated GDP, is a nucleoside diphosphate. It is an ester of pyrophosphoric acid with the nucleoside guanosine. GDP consists of the pyrophosphate group, the pentose sugar ribose, and the nucleobase guanine . Guanosine diphosphate, also known as 5-GDP or 5-diphosphate, guanosine, belongs to the class of organic compounds known as purine ribonucleoside diphosphates. These are purine ribobucleotides with diphosphate group linked to the ribose moiety. Guanosine diphosphate exists in all living species, ranging from bacteria to humans. In humans, guanosine diphosphate is involved in intracellular signalling through adenosine receptor A2B and adenosine. Outside of the human body, Guanosine diphosphate has been detected, but not quantified in several different foods, such as devilfish, java plums, green beans, almonds, and orange mints. Guanosine diphosphate is a purine ribonucleoside 5-diphosphate resulting from the formal condensation of the hydroxy group at the 5 position of guanosine with pyrophosphoric acid. COVID info from COVID-19 Disease Map, PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

ADP, Beta S

Adenosine 5-O-(3-thiodiphophate)

C10H15N5O9P2S (443.0066)


   

8-oxo-dGDP

[({[(2R,3S,5R)-5-(6,8-dihydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C10H15N5O11P2 (443.0243)


8-oxo-dgdp is part of the Purine metabolism pathway. It is a substrate for: ADP-sugar pyrophosphatase.

   

Econazole nitrate

Econazole (nitrate)

C18H16Cl3N3O4 (443.0206)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

ADP, beta S

[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonothioic acid

C10H15N5O9P2S (443.0066)


   

Guanosine diphos-phate

[({[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C10H15N5O11P2 (443.0243)


   

Guanosine-3',5'-Diphosphate

{[5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-4-hydroxy-2-[(phosphonooxy)methyl]oxolan-3-yl]oxy}phosphonic acid

C10H15N5O11P2 (443.0243)


   
   
   
   

Guanosine diphosphate

Guanosine diphosphate

C10H15N5O11P2 (443.0243)


   

Guanosine 5_-diphosphate

Guanosine 5_-diphosphate

C10H15N5O11P2 (443.0243)


   

Guanosine 5-diphosphate

Guanosine 5-diphosphate

C10H15N5O11P2 (443.0243)


   

Guanosine 5′-diphosphate (GDP)

Guanosine 5′-diphosphate (GDP)

C10H15N5O11P2 (443.0243)


   

8-oxo-dGDP

[({[(2R,3S,5R)-5-(6,8-dihydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C10H15N5O11P2 (443.0243)


A purine 2-deoxyribonucleoside 5-diphosphate having 8-oxoguanine as the nucleobase.

   

diazanium,sodium,nitrous acid,rhodium

diazanium,sodium,nitrous acid,rhodium

H13N8NaO12Rh (442.9606)


   
   

7-((2-(triMethylsilyl)ethoxy)Methyl)-2,4-dichloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidine

7-((2-(triMethylsilyl)ethoxy)Methyl)-2,4-dichloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidine

C12H16Cl2IN3OSi (442.9484)


   

2-(2-Chlorophenyl)-3-[(4-methyl-3,5-dinitrophenyl)sulfonyl]-1,3-t hiazolidine

2-(2-Chlorophenyl)-3-[(4-methyl-3,5-dinitrophenyl)sulfonyl]-1,3-t hiazolidine

C16H14ClN3O6S2 (443.0013)


   

disodium 2,4-dihydroxy-5-[(2-hydroxy-3-nitro-5-sulphonatophenyl)azo]benzoate

disodium 2,4-dihydroxy-5-[(2-hydroxy-3-nitro-5-sulphonatophenyl)azo]benzoate

C13H7N3Na2O10S (442.9648)


   

2-(3-Chlorophenyl)-3-[(4-methyl-3,5-dinitrophenyl)sulfonyl]-1,3-t hiazolidine

2-(3-Chlorophenyl)-3-[(4-methyl-3,5-dinitrophenyl)sulfonyl]-1,3-t hiazolidine

C16H14ClN3O6S2 (443.0013)


   

2-(4-Chlorophenyl)-3-[(4-methyl-3,5-dinitrophenyl)sulfonyl]-1,3-t hiazolidine

2-(4-Chlorophenyl)-3-[(4-methyl-3,5-dinitrophenyl)sulfonyl]-1,3-t hiazolidine

C16H14ClN3O6S2 (443.0013)


   

5-BROMO-4-CHLORO-3-INDOLYL B-D-GLUCURONIDE SODIUM SALT TRIHYDRATE

5-BROMO-4-CHLORO-3-INDOLYL B-D-GLUCURONIDE SODIUM SALT TRIHYDRATE

C14H12BrClNNaO7 (442.9383)


   

Orconazole nitrate

Orconazole nitrate

C18H16Cl3N3O4 (443.0206)


C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Guanosine-3,5-Diphosphate

Guanosine-3,5-Diphosphate

C10H15N5O11P2 (443.0243)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies

   

N-(4-bromophenyl)-1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-2-pyrrolecarboxamide

N-(4-bromophenyl)-1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-2-pyrrolecarboxamide

C17H10BrClF3N3O (442.9648)


   

(R)-econazole nitrate

(R)-econazole nitrate

C18H16Cl3N3O4 (443.0206)


   

(S)-econazole nitrate

(S)-econazole nitrate

C18H16Cl3N3O4 (443.0206)


   

3-({[3,5-Difluoro-3-(Trifluoromethoxy)biphenyl-4-Yl]amino}carbonyl)thiophene-2-Carboxylic Acid

3-({[3,5-Difluoro-3-(Trifluoromethoxy)biphenyl-4-Yl]amino}carbonyl)thiophene-2-Carboxylic Acid

C19H10F5NO4S (443.0251)


   

[5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate

[5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate

C10H15N5O11P2 (443.0243)


   

Lucifer yellow carbohydrazide dye(2-)

Lucifer yellow carbohydrazide dye(2-)

C13H9N5O9S2-2 (442.9842)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

Guanosine-5-diphosphate

Guanosine-5-diphosphate

C10H15N5O11P2 (443.0243)


A purine ribonucleoside 5-diphosphate resulting from the formal condensation of the hydroxy group at the 5 position of guanosine with pyrophosphoric acid. COVID info from COVID-19 Disease Map, PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(2s)-n-[2-(5,6-dibromo-1h-indol-3-yl)ethyl]-4-methyl-2-(methylamino)pentanimidic acid

(2s)-n-[2-(5,6-dibromo-1h-indol-3-yl)ethyl]-4-methyl-2-(methylamino)pentanimidic acid

C17H23Br2N3O (443.0208)


   

(2s,3s)-n-[2-(5,6-dibromo-1h-indol-3-yl)ethyl]-3-methyl-2-(methylamino)pentanimidic acid

(2s,3s)-n-[2-(5,6-dibromo-1h-indol-3-yl)ethyl]-3-methyl-2-(methylamino)pentanimidic acid

C17H23Br2N3O (443.0208)


   

(2s,3r)-n-[2-(2,5-dibromo-1h-indol-3-yl)ethyl]-3-methyl-2-(methylamino)pentanimidic acid

(2s,3r)-n-[2-(2,5-dibromo-1h-indol-3-yl)ethyl]-3-methyl-2-(methylamino)pentanimidic acid

C17H23Br2N3O (443.0208)


   

n-[2-(5,6-dibromo-1h-indol-3-yl)ethyl]-4-methyl-2-(methylamino)pentanimidic acid

n-[2-(5,6-dibromo-1h-indol-3-yl)ethyl]-4-methyl-2-(methylamino)pentanimidic acid

C17H23Br2N3O (443.0208)


   

n-[2-(2,5-dibromo-1h-indol-3-yl)ethyl]-4-methyl-2-(methylamino)pentanimidic acid

n-[2-(2,5-dibromo-1h-indol-3-yl)ethyl]-4-methyl-2-(methylamino)pentanimidic acid

C17H23Br2N3O (443.0208)


   

{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxyphosphonic acid

{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxyphosphonic acid

C10H15N5O11P2 (443.0243)


   

(2s)-n-[2-(2,5-dibromo-1h-indol-3-yl)ethyl]-4-methyl-2-(methylamino)pentanimidic acid

(2s)-n-[2-(2,5-dibromo-1h-indol-3-yl)ethyl]-4-methyl-2-(methylamino)pentanimidic acid

C17H23Br2N3O (443.0208)